Eloxx Pharmaceuticals (NASDAQ:ELOX) versus Chromocell Therapeutics (NYSE:CHRO) Head-To-Head Review
Earnings and Valuation This table compares Chromocell Therapeutics and Eloxx Pharmaceuticals”s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chromocell Therapeutics N/A N/A -$7.38 million ($1.24) -1.01 Eloxx Pharmaceuticals N/A N/A -$36.06 million N/A N/A Risk and Volatility Chromocell Therapeutics has a beta of 3.22, […]
Earnings and Valuation This table compares Chromocell Therapeutics and Eloxx Pharmaceuticals”s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chromocell Therapeutics N/A N/A -$7.38 million ($1.24) -1.01 Eloxx Pharmaceuticals N/A N/A -$36.06 million N/A N/A Risk and Volatility Chromocell Therapeutics has a beta of 3.22, […]
